Cardunolizumab

· Zhejiang Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cardunolizumab, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer [Phase 2]

See pricing